Blueshift Asset Management LLC raised its holdings in Bath & Body Works, Inc. (NYSE:BBWI – Free Report) by 48.7% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 26,200 shares of the company’s stock after buying an additional 8,576 shares during the period. Blueshift Asset Management LLC’s holdings in Bath & Body Works were worth $1,016,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also recently bought and sold shares of BBWI. Golden State Wealth Management LLC bought a new stake in Bath & Body Works in the fourth quarter valued at approximately $26,000. SRS Capital Advisors Inc. increased its stake in shares of Bath & Body Works by 99.7% during the fourth quarter. SRS Capital Advisors Inc. now owns 659 shares of the company’s stock worth $26,000 after purchasing an additional 329 shares during the period. True Wealth Design LLC increased its stake in shares of Bath & Body Works by 5,270.0% during the third quarter. True Wealth Design LLC now owns 1,074 shares of the company’s stock worth $34,000 after purchasing an additional 1,054 shares during the period. UMB Bank n.a. increased its stake in shares of Bath & Body Works by 58.8% during the fourth quarter. UMB Bank n.a. now owns 905 shares of the company’s stock worth $35,000 after purchasing an additional 335 shares during the period. Finally, Lindbrook Capital LLC increased its stake in shares of Bath & Body Works by 81.9% during the fourth quarter. Lindbrook Capital LLC now owns 957 shares of the company’s stock worth $37,000 after purchasing an additional 431 shares during the period. Institutional investors own 95.14% of the company’s stock.
Wall Street Analyst Weigh In
A number of brokerages have recently weighed in on BBWI. Barclays lowered their target price on Bath & Body Works from $43.00 to $38.00 and set an “equal weight” rating on the stock in a research note on Monday, March 3rd. Piper Sandler increased their price target on Bath & Body Works from $36.00 to $39.00 and gave the stock a “neutral” rating in a research report on Monday, January 6th. Raymond James reissued an “outperform” rating and set a $46.00 price target (up previously from $42.00) on shares of Bath & Body Works in a research report on Tuesday, February 25th. Cowen reissued a “buy” rating on shares of Bath & Body Works in a research report on Thursday, February 27th. Finally, Robert W. Baird increased their price target on Bath & Body Works from $45.00 to $47.00 and gave the stock an “outperform” rating in a research report on Friday, February 28th. Five investment analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $45.06.
Bath & Body Works Stock Performance
Shares of BBWI stock opened at $30.24 on Thursday. Bath & Body Works, Inc. has a fifty-two week low of $26.21 and a fifty-two week high of $52.99. The company has a market cap of $6.55 billion, a PE ratio of 7.37, a P/E/G ratio of 0.92 and a beta of 1.89. The stock’s fifty day moving average price is $35.96 and its two-hundred day moving average price is $33.96.
Bath & Body Works (NYSE:BBWI – Get Free Report) last issued its quarterly earnings data on Thursday, February 27th. The company reported $2.09 earnings per share for the quarter, topping analysts’ consensus estimates of $2.04 by $0.05. The business had revenue of $2.79 billion for the quarter, compared to analyst estimates of $2.78 billion. Bath & Body Works had a negative return on equity of 44.03% and a net margin of 12.43%. On average, equities analysts predict that Bath & Body Works, Inc. will post 3.3 EPS for the current fiscal year.
Bath & Body Works Announces Dividend
The company also recently disclosed a quarterly dividend, which was paid on Friday, March 7th. Investors of record on Friday, February 21st were given a dividend of $0.20 per share. The ex-dividend date of this dividend was Friday, February 21st. This represents a $0.80 dividend on an annualized basis and a yield of 2.65%. Bath & Body Works’s dividend payout ratio is currently 21.98%.
Bath & Body Works announced that its Board of Directors has authorized a share repurchase program on Thursday, February 27th that permits the company to buyback $500.00 million in outstanding shares. This buyback authorization permits the company to reacquire up to 6.4% of its stock through open market purchases. Stock buyback programs are often a sign that the company’s leadership believes its stock is undervalued.
About Bath & Body Works
Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.
Read More
- Five stocks we like better than Bath & Body Works
- Transportation Stocks Investing
- What GTC 2025 Signals for NVIDIA Stock’s Next Big Move
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Alphabet’s Officially In A Bear Market—Time To Buy?
- The 3 Best Retail Stocks to Shop for in August
- D-Wave and Quantum Supremacy: Implications For Investors
Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.